https://www.selleckchem.com/pr....oducts/asciminib-abl
A total of 15 implants failed after replacement in 11 patients during the first 6 months of follow-up. Of these, nine failures (15.25%) occurred in seven patients (13.21%) after immediate replacement, and six (9.09%) occurred in four patients (7.02%) who underwent delayed replacement. No statistically significant differences were detected between the two groups (P = 0.431). No significant differences in implant survival at sites of previous failure were found according to the timing of implant replacement. No significant differ